Summary
Latest filing:
AH Bio Fund II, L.P. is 10% Owner of Scribe Therapeutics, Inc. (SCTX). 1 SEC Form 4 filing on record, dated 29 July 2026. Most recent open-market trade: bought $5.00M of SCTX on 29 July 2026. Lifetime open-market purchases: $5.00M.
Recent Transactions
3Every recent SEC Form 4 transaction AH Bio Fund II, L.P. has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies AH Bio Fund II, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Behzad Aghazadeh - $36.26M of SCTX open-market activity in the last 12 months
- ORBIMED ADVISORS LLC - $15.00M of SCTX open-market activity in the last 12 months
- Carl L. Gordon - $15.00M of SCTX open-market activity in the last 12 months
- Svetlana Lucas - $45K of SCTX open-market activity in the last 12 months
- David Parrot - $40K of SCTX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
What is AH Bio Fund II, L.P.?
AH Bio Fund II, L.P. is an investment firm, tracked as 10% Owner of Scribe Therapeutics, Inc. (SCTX). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has AH Bio Fund II, L.P. submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has AH Bio Fund II, L.P. been buying or selling stock?
Recorded transactions: 1 open-market purchase ($5.00M) and 0 open-market sales across all tracked filings.
Where can I see all of AH Bio Fund II, L.P.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow AH Bio Fund II, L.P. and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
